Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Cressey

Showing results (121-130 of 160) with videos related to

Pageof 16
Sort By:
The Lancet. HIV|December 9, 2021
Abacavir dosing in neonates from birth to 3 months of life: a population pharmacokinetic modelling and simulation studyAdrie Bekker, Edmund V Capparelli, Avy Violari, et al.
Journal of the Pediatric Infectious Diseases Society|February 17, 2017
Incidence of Tuberculosis and Associated Mortality in a Cohort of Human Immunodeficiency Virus-Infected Children Initiating Antiretroviral TherapyNicolas Salvadori, Nicole Ngo-Giang-Huong, Chloé Duclercq, et al.
Antimicrobial Agents and Chemotherapy|December 13, 2023
Simultaneous pharmacokinetic modeling of unbound and total darunavir with ritonavir in adolescents: a substudy of the SMILE trialSeef Abdalla, Alexandra Compagnucci, Yoann Riault, et al.
Antiviral Therapy|October 23, 2015
Contribution of different antiretroviral regimens containing zidovudine, lamivudine and ritonavir-boosted lopinavir on HIV viral load reduction during pregnancyPatumrat Sripan, Sophie Le Coeur, Lily Ingsrisawang, et al.
Asian Biomedicine : Research, Reviews and News|June 17, 2026
Favipiravir treatment in Thai children with COVID-19: effectiveness, safety, and modeling drug exposureSujittra Chaisavaneeyakorn, Nopporn Apiwattanakul, Chonnamet Techasaensiri, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 7, 2011
A comparison of 3 regimens to prevent nevirapine resistance mutations in HIV-infected pregnant women receiving a single intrapartum dose of nevirapineRussell B Van Dyke, Nicole Ngo-Giang-Huong, David E Shapiro, et al.
The Lancet. Child & Adolescent Health|March 20, 2025
Simplifying medicine dosing for children by harmonising weight bands across therapeutic areasHylke Waalewijn, Mounier Almett, Roeland E Wasmann, et al.
The Lancet. Child & Adolescent Health|April 17, 2025
Accelerating access to paediatric medicines: lessons learned from the Global Accelerator for Paediatric Formulations, a WHO-hosted networkMartina Penazzato, Asma Hafiz, Sébastien Morin, et al.
The Lancet. HIV|July 21, 2022
Advancing the prevention and treatment of HIV in children: priorities for research and developmentMartina Penazzato, Claire L Townsend, Nadia A Sam-Agudu, et al.
The Pediatric Infectious Disease Journal|December 21, 2013
Pharmacokinetics of pediatric lopinavir/ritonavir tablets in children when administered twice daily according to FDA weight bandsDiane E T Bastiaans, Silvia Forcat, Hermione Lyall, et al.
Pageof 16

Showing results (121-130 of 160) with videos related to

Sort By:
Pageof 16
The Lancet. HIV|December 9, 2021
Abacavir dosing in neonates from birth to 3 months of life: a population pharmacokinetic modelling and simulation studyAdrie Bekker, Edmund V Capparelli, Avy Violari, et al.
Journal of the Pediatric Infectious Diseases Society|February 17, 2017
Incidence of Tuberculosis and Associated Mortality in a Cohort of Human Immunodeficiency Virus-Infected Children Initiating Antiretroviral TherapyNicolas Salvadori, Nicole Ngo-Giang-Huong, Chloé Duclercq, et al.
Antimicrobial Agents and Chemotherapy|December 13, 2023
Simultaneous pharmacokinetic modeling of unbound and total darunavir with ritonavir in adolescents: a substudy of the SMILE trialSeef Abdalla, Alexandra Compagnucci, Yoann Riault, et al.
Antiviral Therapy|October 23, 2015
Contribution of different antiretroviral regimens containing zidovudine, lamivudine and ritonavir-boosted lopinavir on HIV viral load reduction during pregnancyPatumrat Sripan, Sophie Le Coeur, Lily Ingsrisawang, et al.
Asian Biomedicine : Research, Reviews and News|June 17, 2026
Favipiravir treatment in Thai children with COVID-19: effectiveness, safety, and modeling drug exposureSujittra Chaisavaneeyakorn, Nopporn Apiwattanakul, Chonnamet Techasaensiri, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 7, 2011
A comparison of 3 regimens to prevent nevirapine resistance mutations in HIV-infected pregnant women receiving a single intrapartum dose of nevirapineRussell B Van Dyke, Nicole Ngo-Giang-Huong, David E Shapiro, et al.
The Lancet. Child & Adolescent Health|March 20, 2025
Simplifying medicine dosing for children by harmonising weight bands across therapeutic areasHylke Waalewijn, Mounier Almett, Roeland E Wasmann, et al.
The Lancet. Child & Adolescent Health|April 17, 2025
Accelerating access to paediatric medicines: lessons learned from the Global Accelerator for Paediatric Formulations, a WHO-hosted networkMartina Penazzato, Asma Hafiz, Sébastien Morin, et al.
The Lancet. HIV|July 21, 2022
Advancing the prevention and treatment of HIV in children: priorities for research and developmentMartina Penazzato, Claire L Townsend, Nadia A Sam-Agudu, et al.
The Pediatric Infectious Disease Journal|December 21, 2013
Pharmacokinetics of pediatric lopinavir/ritonavir tablets in children when administered twice daily according to FDA weight bandsDiane E T Bastiaans, Silvia Forcat, Hermione Lyall, et al.
Pageof 16